Moderna, Inc. (FRA:0QF)
22.91
-1.03 (-4.30%)
Oct 17, 2025, 6:05 PM CET
Moderna Revenue
Moderna had revenue of $142.00M USD in the quarter ending June 30, 2025, a decrease of -41.08%. This brings the company's revenue in the last twelve months to $3.08B, down -39.05% year-over-year. In the year 2024, Moderna had annual revenue of $3.24B, down -52.75%.
Revenue (ttm)
$3.08B
Revenue Growth
-39.05%
P/S Ratio
3.37
Revenue / Employee
$530.69K
Employees
5,800
Market Cap
8.83B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.24B | -3.61B | -52.75% |
| Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
| Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
| Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
| Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 46.17B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.28B |
| Merck KGaA | 21.22B |
| Fresenius Medical Care AG | 19.52B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.68B |
| Fielmann Group AG | 2.40B |
Moderna News
- 2 days ago - mRNA COVID shots may bolster effects of cancer treatments: study - Seeking Alpha
- 2 days ago - Dow Jumps More Than 500 Points Ahead Of Earnings: Investor Fear Eases, Greed Index Remains In 'Fear' Zone - Benzinga
- 3 days ago - Monday Sector Leaders: Healthcare, Technology & Communications - Nasdaq
- 3 days ago - Needham Reiterates Hold Rating for Moderna (MRNA) on October 20, 2025 | MRNA Stock News - GuruFocus
- 3 days ago - Stock Market Today: S&P 500, Nasdaq, Dow Jones Futures Rise— Micron, Bitmine, Coinbase In Focus - Benzinga
- 4 days ago - Moderna (MRNA) Reveals Promising Data for Influenza Vaccines at IDWeek 2025 - GuruFocus
- 4 days ago - Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025 - Wallstreet:Online
- 4 days ago - Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025 - Accesswire